DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

Discover why DexCom (DXCM) could rebound in 2025. Explore buyback plans, growth potential, and investment insights in the ...

Connacht are staying silent on the expected signing of Leinster back Ciarán Frawley, with Stuart Lancaster refusing to ...

Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...

Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...

One of the main threads running through our most-read stories of 2025—as much as ever in the medtech industry writ large—is ...

One of the Apple Watch’s biggest threats has no screen, weighs about a fifth of an ounce and charges a monthly subscription ...

Our study assessed the impact of using Control-IQ technology, an automated insulin delivery system, on achievement of a Healthcare Effectiveness Data and Information Set (HEDIS) quality measure ...

It's true Oura partners with Palantir Technologies, a software company that serves the U.S. government. But some claims about ...

Indiana Wish has granted 3,600 wishes to kids with a life-threatening diagnosis, and provided one Indiana girl with a dog ...